Chemoinformaics analysis of Cis-Linalool-Oxide
| Molecular Weight | 212.289 | nRot | 2 |
| Heavy Atom Molecular Weight | 192.129 | nRig | 8 |
| Exact Molecular Weight | 212.141 | nRing | 1 |
| Solubility: LogS | -1.696 | nHRing | 1 |
| Solubility: LogP | 2.236 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 35.7819 |
| nHD | 0 | BPOL | 24.4041 |
| QED | 0.521 |
| Synth | 3.8 |
| Natural Product Likeliness | 3.074 |
| NR-PPAR-gamma | 0.153 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.035 |
| Pgp-sub | 0.001 |
| HIA | 0.008 |
| CACO-2 | -4.449 |
| MDCK | 0.0000251 |
| BBB | 0.949 |
| PPB | 0.723678 |
| VDSS | 1.465 |
| FU | 0.409952 |
| CYP1A2-inh | 0.028 |
| CYP1A2-sub | 0.204 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.907 |
| CYP2c9-inh | 0.025 |
| CYP2c9-sub | 0.306 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.574 |
| CYP3a4-inh | 0.278 |
| CYP3a4-sub | 0.417 |
| CL | 4.436 |
| T12 | 0.54 |
| hERG | 0.009 |
| Ames | 0.035 |
| ROA | 0.018 |
| SkinSen | 0.135 |
| Carcinogencity | 0.571 |
| EI | 0.665 |
| Respiratory | 0.087 |
| NR-Aromatase | 0.01 |
| Antiviral | Yes |
| Prediction | 0.593192 |